APGE
Price
$35.50
Change
+$0.11 (+0.31%)
Updated
Aug 11, 11:45 AM (EDT)
Capitalization
2.06B
21 days until earnings call
GPCR
Price
$16.43
Change
+$0.12 (+0.74%)
Updated
Aug 11, 03:04 PM (EDT)
Capitalization
939.42M
Interact to see
Advertisement

APGE vs GPCR

Header iconAPGE vs GPCR Comparison
Open Charts APGE vs GPCRBanner chart's image
Apogee Therapeutics
Price$35.50
Change+$0.11 (+0.31%)
Volume$300
Capitalization2.06B
Structure Therapeutics
Price$16.43
Change+$0.12 (+0.74%)
Volume$100
Capitalization939.42M
APGE vs GPCR Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. GPCR commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (APGE: $35.39 vs. GPCR: $16.31)
Brand notoriety: APGE and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 61% vs. GPCR: 142%
Market capitalization -- APGE: $2.06B vs. GPCR: $939.42M
APGE [@Biotechnology] is valued at $2.06B. GPCR’s [@Biotechnology] market capitalization is $939.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both APGE and GPCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 7 bearish.
  • GPCR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -6.25% price change this week, while GPCR (@Biotechnology) price change was -7.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.49%. For the same industry, the average monthly price growth was +31.98%, and the average quarterly price growth was +19.31%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

Industries' Descriptions

@Biotechnology (+22.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.06B) has a higher market cap than GPCR($939M). APGE YTD gains are higher at: -21.876 vs. GPCR (-39.860). GPCR has higher annual earnings (EBITDA): -181.48M vs. APGE (-241.42M). GPCR has more cash in the bank: 837M vs. APGE (513M). GPCR has less debt than APGE: GPCR (7.59M) vs APGE (11.8M). APGE (0) and GPCR (0) have equivalent revenues.
APGEGPCRAPGE / GPCR
Capitalization2.06B939M220%
EBITDA-241.42M-181.48M133%
Gain YTD-21.876-39.86055%
P/E RatioN/AN/A-
Revenue00-
Total Cash513M837M61%
Total Debt11.8M7.59M156%
TECHNICAL ANALYSIS
Technical Analysis
APGEGPCR
RSI
ODDS (%)
Bearish Trend 6 days ago
58%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 29 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ILGGX23.530.16
+0.68%
Columbia Integrated Large Cap Gr Instl
IYGIX42.870.28
+0.66%
Macquarie Large Cap Growth Fund I
TSRMX15.99-0.05
-0.31%
Touchstone Sands Cptl Emerg Mkts Gr R6
RYUIX65.84-0.27
-0.41%
Rydex Utilities Inv
TIRRX11.15-0.11
-0.98%
T. Rowe Price Real Estate I

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-1.69%
SYRE - APGE
52%
Loosely correlated
N/A
CRNX - APGE
50%
Loosely correlated
-3.69%
ERAS - APGE
48%
Loosely correlated
-4.11%
CLDX - APGE
48%
Loosely correlated
-2.59%
IDYA - APGE
48%
Loosely correlated
+3.08%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with VKTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+0.68%
VKTX - GPCR
45%
Loosely correlated
+6.55%
DNLI - GPCR
42%
Loosely correlated
-1.90%
CRNX - GPCR
42%
Loosely correlated
-3.69%
CLDX - GPCR
41%
Loosely correlated
-2.59%
APGE - GPCR
41%
Loosely correlated
-1.69%
More